Silence Therapeutics Plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Silence Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Silence Therapeutics Plc - ADR
Rating: 1.98416675
Author: Trendlyne DVM scores

about

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates bot...

6.61 -0.55 (-7.68%)

63.86% Fall from 52W High

211.8K

XNAS Volume

XNAS 03 Nov, 2025 4:01 PM (EST)

Board Meeting

The next board meeting for Silence Therapeutics Plc - ADR is on 14 Nov 2025 for the purpose of Silence Therapeutics PLC Third Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

6.7 / 100

Technically Bullish

72.7 / 100

1Yr Price target upside is 411%

5 analysts

Silence Therapeutics Plc ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Silence Therapeutics Plc - ADR Live Stock Price Today, Share Analysis and Chart

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates bot...

63.86% Fall from 52W High

SWOT Analysis

Silence Therapeutics Plc ADR Live Price Chart